This is another milestone for AquaBounty Technologies towards its pending approval of its AquAdvantage salmon product from the FDA.
AquAdvantage Salmon is a genetically-engineered Atlantic salmon with a rapid-growth phenotype that has been developed over the past 15 years.
In an Environmental Assessment, the VMAC has said, that AquAdvantage salmon are highly unlikely to cause any significant effects on the environment, inclusive of the global commons, foreign nations and stocks of wild Atlantic salmon.
On 19-20 September, the VMAC will meet to discuss and vote on AquaBounty’s application.
|-||Go to our previous news item on this story by clicking here.|